Over 3 million Americans with asthma can't afford to take their medications as prescribed, a new poll estimates. In total, ...

Diagnosing CSU can be difficult for a few main reasons, including the following: CSU is often misdiagnosed because hives are ...

A Northwest Baltimore apartment complex that houses many disabled and elderly residents does not have a working elevator, which the residents say happens often.

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulm ...

It’s more than 10 years since the publication of the National Review of Asthma Deaths, which revealed that most deaths from asthma in the UK were preventable.1 In the years since, many of the problems ...

Treatment focuses on management of symptoms. This includes medications to ease cough and physical discomfort and to lower fever.

Despite a fall in the number of people with asthma over the past decade who say that cost has stopped them taking their meds ...

From 2011-2022, the prevalence of cost-related non-adherence decreased from 23.2% to 13.1%. However, about one in six adults with asthma (17.8%) reported they did not adhere to their asthma ...

Postnasal drip — the constant feeling of mucus trickling down the back of your throat — is often linked to sinusitis (a sinus ...

Flu cases spike in children – can you prevent them catching it and what should parents know? - A doctor talks to Lisa Salmon ...

South Korea's pharmaceutical giant Celltrion on Monday said that it has received approval from Canadian health authorities for a biosimilar treatment for allergic asthma. The company said that its ...

South Korean biopharmaceutical firm Celltrion said Monday that it has received approval from Health Canada for Omlyclo, its omalizumab biosimilar referencing Xolair, designed to treat allergic asthma ...